CSN Chesnara PLC

Hardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets

Hardman & Co Research
Hardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets

12-Sep-2022 / 07:15 GMT/BST


Hardman & Co Research on Chesnara Plc (CSN):

Robust cash generation in challenging markets

 

Chesnara has announced its 2022 half-year results. With weak equity markets and rising interest rates and credit spreads, the risk asset exposure weighed on results. Economic Value profit came in at a loss of £89.6m, compared with a profit of £38.5m in 1H’21. The balance sheet Economic Value also reduced from 416p at the year-end to 351p at 30 June 2022. Group cash generation, the movement in its surplus, was much more robust. Base generation for the group was £21.9m, more than the figure for 2021 as a whole. As expected, the interim dividend was increased by 3% to 8.12p per share.

 

Please click on the link below for the full report:

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co
1 Frederick’s Place

London

EC2R 8AE

Follow us on Twitter @HardmanandCo

Contact:

Brian Moretta



+44(0)203 693 7075

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1439765  12-Sep-2022 

fncls.ssp?fn=show_t_gif&application_id=1439765&application_name=news&site_id=research_pool
EN
12/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chesnara PLC

Brian Moretta ... (+3)
  • Brian Moretta
  • Jason Streets
  • Mark Thomas

Hardman & Co Monthly: May 2025

Feature article: Attractive asset managers - Radical derating presumes things only get worse The UK asset management sector has been significantly derated over the past couple of years. It has faced the dual problem of a shift towards passives and to private assets and away from traditional listed equities and bonds. However, the sector’s assets haven’t collapsed; its margins have proved relatively robust and its profits fairly stable, even against all the rising costs. The clear implication, ...

Brian Moretta
  • Brian Moretta

Chesnara plc (CSN): Showing good operational progress

Chesnara announced its 2024 results, which showed positive progress compared with 2023. The main features were positive market returns, offset by some mixed operational experience. Economic Value profit of £69.1m represented a 17% increase on the £59.1m in 2023. Economic Value increased to £531m, up slightly on £525m 12 months earlier, with a negative forex impact as well as dividend payment. Cash generation was excellent, with base cash increasing to £51.6m and commercial cash to £59.6m. The di...

 PRESS RELEASE

Hardman & Co research on Chesnara plc (CSN): Showing good operational ...

Hardman & Co Research Hardman & Co research on Chesnara plc (CSN): Showing good operational progress 07-Apr-2025 / 14:20 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on Chesnara plc (CSN): Showing good operational progress   Chesnara announced its 2024 results, which showed positive progress compared with 2023. The main features were positive market returns, offset by some mixed operational experience. Economic Value profit of £69.1m represented a 17% increase on the £59.1m in 2023. Economic Value increased to £531m, up ...

Chesnara: 2 directors

Two Directors at Chesnara bought 25,695 shares at between 271p and 272p. The significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Brian Moretta ... (+3)
  • Brian Moretta
  • Mark Thomas
  • Martin Hall

Hardman & Co Monthly: January 2025

Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from pro...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch